Wyeth LLC v. AstraZeneca Pharms. LP
Announcement from a bar association
Headline as published by Illinois Lawyer Now (ISBA) on Oct 23, 2026; collected by the wire Oct 23, 2026, 1:16 PM ET.
Fed. Cir. Docket No. 2024-2325LOURIE, LINN, HUGHESJuly 9, 2026 Brief Summary: Wyeth’s claims invalidated for lack of enablement because the specification did not sufficiently disclose a “unit dosage” producing a therapeutic effect in a patient, or teach how to make that determination. Summary: Wyeth asserted claims 1, 3, and 9 of U.S. Patent No. 10,603,314... Continue Reading
Coverage
Topics
- Bar and practice newsFrom the publisher’s section: no phrase in the text matched, so the tag comes from where Illinois Lawyer Now (ISBA) filed it.
Explore the named firms, organizations and MDL dockets above. Sources and method